| Identification | Back Directory | [Name]
Tesnatilimab | [CAS]
2242758-08-1 | [Synonyms]
Tesnatilimab
Tesnatilimab (anti-NKG2D)
Research Grade Tesnatilimab (DHD72101) |
| Hazard Information | Back Directory | [Uses]
Tesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD)[1][2]. | [References]
[1] Kasper Vadstrup, et al. Anti-NKG2D mAb: A New Treatment for Crohn's Disease? Int J Mol Sci. 2017 Sep 16;18(9):1997. DOI:10.3390/ijms18091997
[2] Wei L, et al. The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy[J]. International Journal of Molecular Sciences, 2023, 24(24): 17545. DOI:10.3390/ijms242417545 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|